Optimising the therapeutic ratio of radioimmunotherapy : an investigation of the roles of chimerisation, fractionation and radiation dosimetry
Radioimmunotherapy (RIT) is a targeted form of treatment for cancer which uses tumour-associated antibodies to selectively deliver a therapeutic radionuclide to sites of disease. In lymphoma, radioimmunotherapy has proved a remarkably effective agent due to the high radiosensitivity of the tumour an...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2007
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.719072 |